Mechanisms by Which Liposomes Improve Inhaled Drug Delivery for Alveolar Diseases

Diseases of the pulmonary alveolus, such as pulmonary fibrosis, are leading causes of morbidity and mortality, but exceedingly few drugs are developed for them. A major reason for this gap is that after inhalation, drugs are quickly whisked away from alveoli due to their high perfusion. To solve thi...

Descripción completa

Detalles Bibliográficos
Autores principales: Ferguson, Laura T., Ma, Xiaonan, Myerson, Jacob W., Wu, Jichuan, Glassman, Patrick M., Zamora, Marco E., Hood, Elizabeth D., Zaleski, Michael, Shen, Mengwen, Essien, Eno-Obong, Shuvaev, Vladimir V., Brenner, Jacob S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10231510/
https://www.ncbi.nlm.nih.gov/pubmed/37266328
http://dx.doi.org/10.1002/anbr.202200106

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10231510/
https://www.ncbi.nlm.nih.gov/pubmed/37266328
http://dx.doi.org/10.1002/anbr.202200106

Ejemplares similares